HomeMAIA • NYSEAMERICAN
add
Maia Biotechnology Inc
Previous close
$1.20
Day range
$1.15 - $1.21
Year range
$0.87 - $2.74
Market cap
44.44M USD
Avg Volume
690.31K
P/E ratio
-
Dividend yield
-
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 9.36M | 123.49% |
Net income | -8.90M | -225.41% |
Net profit margin | — | — |
Earnings per share | -0.27 | -145.45% |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 10.89M | 25.33% |
Total assets | 11.78M | 27.47% |
Total liabilities | 11.74M | 53.99% |
Total equity | 41.67K | — |
Shares outstanding | 37.03M | — |
Price to book | ∞ | — |
Return on assets | -205.03% | — |
Return on capital | -1,194.50% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -8.90M | -225.41% |
Cash from operations | -3.49M | 1.08% |
Cash from investing | — | — |
Cash from financing | 4.23M | 575.60% |
Net change in cash | 747.21K | 125.87% |
Free cash flow | -217.86K | 89.99% |
About
MAIA Biotechnology, Inc. is a public, immune-oncology company based in Chicago, IL focused on the development of telomere targeting agents for the treatment of telomerase-positive cancer cells. Wikipedia
Founded
2018
Headquarters
Website
Employees
13
